[ad_1] The publication of a manuscript entitled HIV/AIDS Vaccines: 2018, was announced by GeoVax Labs, Inc. a biotechnology company developing human vaccines. This manuscript was authored by Harriet L. Robinson, Ph.D., GeoVax’s …
Read More »
[ad_1] BOTHELL, Wash .– ( BUSINESS SONGS ) – The second point above the boilerplate "About Tucatinib" should read: "ORR was 47 percent (n = 16/34)" (instead of "ORR was 47 percent …
Read More »
[ad_1] July 11, 2018 The results of the Phase 1b clinical trials published in JAMA Oncology are promising for the association of tucatinib (formerly ONT-380) with T-DM1 against HER2-positive breast cancer heavily …
Read More »